Viome, a Washington-based biotech startup, is revolutionizing disease detection through at-home testing kits that analyze saliva, stool, and blood samples using RNA technology. The company provides personalized health insights using AI, helping users avoid certain foods or take specified probiotics. With over half a million kits sold and backing from significant investors, Viome is scaling its operations to detect early signs of severe diseases like cancer. The collaboration between research and technology teams is critical to ensure the tools' scientific accuracy and market readiness, especially as consumer interest in home testing increases amidst growing market demand.
It's not just cooperation, it's an embedded model where scientists and engineers work together from day one to ensure accuracy and compliance.
The test kits we've developed have shown promising results in early disease detection, potentially saving lives through timely, personalized health recommendations.
Collection
[
|
...
]